Astria Therapeutics (ATXS) Short Interest Ratio & Short Volume → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free ATXS Stock Alerts $9.17 +0.17 (+1.89%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Astria Therapeutics Short Interest DataCurrent Short Volume5,050,000 sharesPrevious Short Volume5,060,000 sharesChange Vs. Previous Month-0.20%Dollar Volume Sold Short$54.99 millionShort Interest Ratio / Days to Cover4.9Last Record DateApril 15, 2024Outstanding Shares54,910,000 sharesFloat Size44,560,000 sharesShort Percent of Float11.33%Today's Trading Volume1,324,385 sharesAverage Trading Volume979,092 sharesToday's Volume Vs. Average135% Short Selling Astria Therapeutics ? Sign up to receive the latest short interest report for Astria Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatATXS Short Interest Over TimeATXS Days to Cover Over TimeATXS Percentage of Float Shorted Over Time Ad WealthPressIt’s now possible to know the win rate of every trade… BEFORE you take it! Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << Astria Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20245,050,000 shares $54.99 million -0.2%11.3%4.9 $10.89 3/31/20245,060,000 shares $71.22 million +151.7%11.4%4.9 $14.08 3/15/20242,010,000 shares $31.07 million +18.2%4.5%1.9 $15.46 2/29/20241,700,000 shares $24.17 million -13.3%3.8%2.2 $14.22 2/15/20241,960,000 shares $27.83 million -4.4%5.0%2.8 $14.20 1/31/20242,050,000 shares $26.71 million +42.4%5.3%3.2 $13.03 Get the Latest News and Ratings for ATXS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Astria Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/20241,440,000 shares $10.07 million -2.7%5.4%2.8 $6.99 12/31/20231,480,000 shares $11.37 million +62.1%4.8%3.2 $7.68 12/15/2023912,800 shares $5.71 million +10.4%2.7%2.4 $6.25 11/30/2023827,200 shares $3.85 million +23.0%2.5%3.7 $4.65 11/15/2023672,600 shares $3.02 million -13.0%2.0%3.6 $4.49 10/31/2023772,800 shares $3.86 million -11.0%3.0%4.2 $4.99 10/15/2023868,600 shares $5.54 million -7.3%3.3%5.1 $6.38 9/30/2023937,100 shares $6.99 million +1.2%3.6%5.6 $7.46 9/15/2023925,800 shares $7.33 million +5.2%3.6%5.2 $7.92 8/31/2023879,800 shares $7.83 million -0.3%3.4%3.5 $8.90 8/15/2023882,300 shares $7.30 million -14.3%3.4%3.3 $8.27 7/31/20231,030,000 shares $9.23 million -18.3%3.7%4 $8.96 7/15/20231,260,000 shares $11.67 million +4.1%4.5%5.1 $9.26 6/30/20231,210,000 shares $10.08 million +129.5%4.4%5.1 $8.33 6/15/2023527,300 shares $5.37 million -1.8%1.9%2.3 $10.18 5/31/2023536,700 shares $5.87 million -2.9%1.9%2.8 $10.94 5/15/2023552,500 shares $6.80 million -4.9%2.1%2.5 $12.32 4/30/2023580,900 shares $7.58 million +1.3%2.2%2.6 $13.05 4/15/2023573,400 shares $6.34 million -16.1%2.2%2.6 $11.05 3/31/2023683,300 shares $9.09 million +136.7%2.8%3.2 $13.30 3/15/2023288,700 shares $3.31 million +33.0%1.9%1.2 $11.48 2/28/2023217,000 shares $2.64 million -1.4%1.4%1 $12.18 2/15/2023220,100 shares $2.98 million +8.0%1.5%1.4 $13.56 1/31/2023203,900 shares $2.80 million +20.2%1.3%1.3 $13.75 1/15/2023169,700 shares $2.42 million +64.1%1.1%1.1 $14.24 12/30/2022103,400 shares $1.54 million +6.5%0.7%0.7 $14.89 12/15/202297,100 shares $1.09 million +12.4%0.6%0.7 $11.26 11/30/202286,400 shares $868,320.00 +8.3%0.6%0.8 $10.05 11/15/202279,800 shares $685,482.00 -24.9%0.5%0.5 $8.59 10/31/2022106,200 shares $1.02 million -0.3%0.8%0.6 $9.62 10/15/2022106,500 shares $978,735.00 +5.3%0.8%0.6 $9.19 9/30/2022101,100 shares $913,944.00 +8.2%0.9%0.6 $9.04 9/15/202293,400 shares $895,706.00 +3.0%0.8%0.5 $9.59 8/31/202290,700 shares $779,113.00 -49.0%0.8%0.5 $8.59It’s now possible to know the win rate of every trade… BEFORE you take it! (Ad)Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets. >> You can grab your FREE, laminated copies right here << ATXS Short Interest - Frequently Asked Questions What is Astria Therapeutics' current short interest? Short interest is the volume of Astria Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 5,050,000 shares of ATXS short. 11.33% of Astria Therapeutics' shares are currently sold short. Learn More on Astria Therapeutics' current short interest. What is a good short interest ratio for Astria Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ATXS shares currently have a short interest ratio of 5.0. Learn More on Astria Therapeutics's short interest ratio. Which institutional investors are shorting Astria Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Astria Therapeutics: Simplex Trading LLC, Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Astria Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.33% of Astria Therapeutics' floating shares are currently sold short. Is Astria Therapeutics' short interest increasing or decreasing? Astria Therapeutics saw a drop in short interest in April. As of April 15th, there was short interest totaling 5,050,000 shares, a drop of 0.2% from the previous total of 5,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Astria Therapeutics' float size? Astria Therapeutics currently has issued a total of 54,910,000 shares. Some of Astria Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Astria Therapeutics currently has a public float of 44,560,000 shares. How does Astria Therapeutics' short interest compare to its competitors? 11.33% of Astria Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Astria Therapeutics: Phathom Pharmaceuticals, Inc. (43.45%), Altimmune, Inc. (28.73%), Stoke Therapeutics, Inc. (11.94%), Korro Bio, Inc. (2.58%), AnaptysBio, Inc. (18.01%), COMPASS Pathways plc (5.39%), Calliditas Therapeutics AB (publ) (0.02%), Phibro Animal Health Co. (3.10%), Olema Pharmaceuticals, Inc. (16.04%), Arbutus Biopharma Co. (2.88%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Astria Therapeutics stock? Short selling ATXS is an investing strategy that aims to generate trading profit from Astria Therapeutics as its price is falling. ATXS shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Astria Therapeutics? A short squeeze for Astria Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ATXS, which in turn drives the price of the stock up even further. How often is Astria Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ATXS, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: PHAT Short Interest ALT Short Interest STOK Short Interest KRRO Short Interest ANAB Short Interest CMPS Short Interest CALT Short Interest PAHC Short Interest OLMA Short Interest ABUS Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ATXS) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe AI stock to buy right nowStockEarningsThe only accurate crypto trading system I know …Weiss Ratings